Cancer
Resistance to Anti-PD-1 Therapy in Cancer Reveals New Mechanisms
Research conducted by a team of scientists at Zhejiang University School of Medicine has shed new light on the mechanisms behind resistance to anti-PD-1 therapy in non-small cell lung cancer (NSCLC). The study, published in the Journal for ImmunoTherapy of Cancer, found that galectin-9 expressing tumor cells play a crucial